According to a PubMed Central publication, PCOS is deeply connected to insulin resistance, which is why medications that control blood sugar are highly effective for treating it
J Hazard Mater 403:123922
GLP-1 receptor agonists as a drug class have substantial clinical trial evidence supporting significant weight loss outcomes, with peer-reviewed research demonstrating statistically meaningful reductions in body weight in large randomized controlled trials
Patients should be monitored for gallbladder symptoms, as rapid weight loss increases the risk of gallstones
May reduce the action of interferon alpha
Semaglutide (Wegovy, Ozempic) aims at one receptor (GLP-1), while tirzepatide (Zepbound, Mounjaro) homes in on two (GLP-1 and GIP)